Actavis urges appeals court to allow Alzheimer's drug 'hard switch'
A plan to withdraw an obsolete version of an Alzheimer's drug is legal, drug company Actavis argued, urging a federal appeals court to reverse a decision that blocked its plan to...To view the full article, register now.
Already a subscriber? Click here to view full article